Evidence map›Paper›PMID 38062767›Full record

ArticleThyroid : official journal of the American Thyroid Association2024

Presumed Pathogenic Germ Line and Somatic Variants in African American Thyroid Cancer.

Zachary A Hurst, Sandya Liyanarachchi, Pamela Brock, Huiling He, Fadi Nabhan, Colleen Veloski, Amanda E Toland, Matthew D Ringel, Sissy M Jhiang

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Thyroid : official journal of the American Thyroid Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Zachary A HurstDivision of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio, USA.
Sandya LiyanarachchiDepartment of Molecular Medicine and Therapeutics, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio, USA.
Pamela BrockDivision of Human Genetics, Department of Internal Medicine, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio, USA.
Huiling HeDepartment of Molecular Medicine and Therapeutics, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio, USA.
Fadi NabhanDivision of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio, USA.
Colleen VeloskiDepartment of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, Florida, USA.
Amanda E TolandDivision of Human Genetics, Department of Internal Medicine, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio, USA.
Matthew D RingelDepartment of Molecular Medicine and Therapeutics, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio, USA.
Sissy M JhiangDepartment of Physiology and Cell Biology, The Ohio State University College of Medicine, Columbus, Ohio, USA.
The Ohio State University · USCancer Genetics (United States) · USMoffitt Cancer Center · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Daniel G. Stover · 1985 to 2026
$132.3M
Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Aaron Robert Goldman · 1985 to 2026
$75.9M
The Ohio State University and MD Anderson Cancer Center Thyroid Cancer SPOREP50CA168505 · NCI · OHIO STATE UNIVERSITY · PI DE LA CHAPELLE, ALBERT · 2013 to 2017
$10.9M
Racial differences in Immunogenetic Tumorigenesis of Head and Neck Squamous Cell CarcinomaR01CA265975 · NCI · JOHNS HOPKINS UNIVERSITY · PI DAVID SIDRANSKY, Amanda Ewart Toland · 2022 to 2026
$2.2M
Impact of germline variants on racial and ethnic differences in somatic mutation frequencyR01CA215151 · NCI · OHIO STATE UNIVERSITY · PI TOLAND, AMANDA EWART · 2018 to 2022
$1.8M
NCI NIH HHS P30 CA010815NCI NIH HHS P30 CA016058NCI NIH HHS P50 CA168505NCI NIH HHS R01 CA215151NCI NIH HHS R01 CA265975
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Thyroid Carcinoma, AnaplasticThyroid NeoplasmsBlack or African AmericanGenetic Predisposition to DiseaseHumansThyroid Cancer, PapillaryAfrican American thyroid cancercancer predispositioncardiovascular riskpathogenic germ line variantspathogenic somatic variants

Identifiers

PMID38062767
PMCPMC10951570
OpenAlexW4389486146

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.